Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)
Taiwan · Delayed Price · Currency is TWD 24.45
-0.15 (-0.61%)
Jan 22, 2026, 10:38 AM CST
Genomics BioSci & Tech. Revenue
Genomics BioSci & Tech. had revenue of 178.01M TWD in the quarter ending September 30, 2025, with 33.63% growth. This brings the company's revenue in the last twelve months to 607.89M, up 30.62% year-over-year. In the year 2024, Genomics BioSci & Tech. had annual revenue of 482.75M with 21.86% growth.
Revenue (ttm)
607.89M
Revenue Growth
+30.62%
P/S Ratio
2.93
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 482.75M | 86.61M | 21.86% |
| Dec 31, 2023 | 396.14M | -22.86M | -5.46% |
| Dec 31, 2022 | 419.00M | 29.04M | 7.45% |
| Dec 31, 2021 | 389.97M | -53.21M | -12.01% |
| Dec 31, 2020 | 443.18M | 15.52M | 3.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chunghwa Chemical Synthesis & Biotech | 977.79M |
| Meribank Biotech | 486.52M |
| GenMont Biotech Incorporation | 391.48M |
| Abnova (Taiwan) | 355.40M |
| NeoCore Technology | 190.10M |
| Gwo Xi Stem Cell Applied Technology Co. , | 184.91M |
| Enimmune corporation | 42.23M |
| TaiRx | 15.46M |